Dr. Kubek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 W University Avenue
Suite 403
Muncie, IN 47304Phone+1 765-751-1700
Education & Training
- Carolinas Medical CenterFellowship, Craniofacial Surgery and Pediatric Plastic Surgery, 2015
- University of Colorado School of MedicineResidency, Plastic Surgery - Integrated, 2012 - 2015
- Carolinas Medical CenterResidency, Surgery, 2008 - 2012
- Western Michigan University Homer Stryker MD School of MedicineInternship, Transitional Year, 2007 - 2008
- Michigan State University College of Human MedicineClass of 2007
Certifications & Licensure
- IN State Medical License 2017 - 2025
- NC State Medical License 2008 - 2018
- NE State Medical License 2016 - 2018
- CO State Medical License 2012 - 2017
- MI State Medical License 2007 - 2008
- American Board of Plastic Surgery Plastic Surgery
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 4 citationsNo Residual Basal Cell Carcinoma after Excision for Biopsy-proven Tumor: Clinical and Medicolegal ImplicationsRaffi Gurunluoglu, Eddie Kubek, Jamie Arton, Adam Olsen, Michael Bronsert
Plastic and Reconstructive Surgery. Global Open. 2013-12-01 - 12 citationsDual Pedicle Mastopexy Technique for Reorientation of Volume and Shape After Subglandular and Submuscular Breast Implant RemovalRaffi Gurunluoglu, Edward W. Kubek, Jamie Arton
Eplasty. 2013-09-16 - 2 citationsThe protective effect of the blood brain barrier from systemic cytokines in an animal femur fracture model.Mickey M. Ott, Alan T. Davis, Wayne E. Vanderkolk, James H. Resau, David H. DeHeer
The Journal of Trauma. 2007-09-01
Journal Articles
- Dual pedicle mastopexy technique for reorientation of volume and shape after subglandular and submuscular breast implant removalGurunluoglu, R, Kubek E, Arton J, Eplasty, 9/16/2013
Books/Book Chapters
Research History
- Founder and Chief Medical Officer, ChemoKind IncChemoKind's proprietary therapeutic platforms make possible the removal of disease causing organisms/cells by way of directed chemotaxis. Using this strategy, offending cells are removed, not killed, thus, instead of developing resistance, organisms become more sensitive to therapy over time.2015 - Present
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: